Industry
Featured experience
Endo $6.7 billion merger with Mallinckrodt
We are advising Endo on the transaction
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
Charles River Laboratories cooperation agreement with Elliott
We are advising Charles River on the agreement
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Ardelyx, Inc. $144 Million Follow-On Public Offering
Davis Polk advised the joint book-running managers for the public offering of common stock by Ardelyx, Inc for gross…
Millendo Therapeutics, Inc. $25 Million Offering of Common Shares
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with…
Kodiak Sciences Inc. $317 Million Follow-On Offering
Davis Polk advised the joint bookrunning managers and representatives of the several underwriters in connection with a $317…
Revance Therapeutics, Inc. $110 Million Common Stock Offering
Davis Polk advised the joint lead book-running managers and representatives of the several underwriters in connection…
AbbVie Inc. $30 Billion Senior Notes Offering
Davis Polk advised the initial purchasers in connection with an unregistered offering by AbbVie Inc. of $30 billion…
Davis Polk Advises Roche on Its Acquisition of Promedior
Davis Polk is advising Roche on its acquisition of Promedior, Inc. Under the terms of the merger agreement, Roche will make…
Davis Polk Advises Shockwave Medical, Inc. on Its $90 Million Public Offering
Davis Polk advised Shockwave Medical, Inc. on its SEC-registered public offering of 2,481,781 shares of common stock for an…
Affimed N.V. $34.5 Million Offering of Common Shares
Davis Polk advised the underwriters in connection with the $34.5 million public offering of 13,800,000 common shares of…
Agios Pharmaceuticals, Inc. Common Stock Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the…
Applied Therapeutics, Inc. Common Stock PIPE Offering
Davis Polk advised the placement agents in connection with a private placement of shares of common stock of Applied…